Fully laparoscopic bowel closure during anastomosis

SEGER’s IDEATM laparoscopic bowel closure device enables
fast and easy 100% Intracorporeal Laparoscopic Anastomoses.

SEGER IDEA^TM

Seger’s Novel Solution – LAP IA^TM

Bowel resection surgery involves removing all or part of the intestine. After resection, the surgeon creates a common opening in the two bowel sections to connect them (anastomosis).

Laparoscopic bowel resection and anastomosis is a preferred method over open surgery because of its clinical benefits to the patient. At present, the majority of resections and anastomoses are performed outside the abdomen (extracorporeal). While Extracorporeal Laparoscopic Surgery may still be preferred in certain cases due to familiarity or perceived ease of extracorporeal anastomosis, Intracorporeal Laparoscopic Surgery is increasingly favored in advanced laparoscopic and robotic surgery for its superior patient outcomes. The reason is the difficulty and complexity of laparoscopic suturing by surgeons.

SEGER Surgical Solutions introduces the SEGER IDEA^TM, a laparoscopic bowel closure device that quickly and securely aligns, closes, and staples the common enterotomy to allow 100% intracorporeal anastomosis, without the need for suturing.

The IDEA is introduced via a standard 12-millimeter trocar.

The SEGER IDEA^TM improves patient care, provides better outcomes, and reduces health care costs.

Improves Patient Care

Fewer surgical site infections (SSIs)
Fewer incisional hernias
Smaller incisions, more cosmetically placed

Results in Better Outcomes

Requires smaller incisions
Eliminates risk of bowel twisting
Reduces need for additional surgery

Cuts Health Care Costs

Reduces procedure time
Reduces post-op complications
Shortens length of stay (LOS)

About Us

SEGER Surgical Solutions is developing the first easy-to-use closure device that enables 100% Intracorporeal anastomosis.

The SEGER IDEATM is a laparoscopic stapler that enables not only to make the anastomoses but also to close the common enterotomy intracorporeally.

Intracorporeal laparoscopic surgery offers less trauma, faster recovery, reduced pain, smaller incisions, and fewer complications compared to extracorporeal techniques.

SEGER IDEA™ is your first step towards 100% Intracorporeal Anastomoses

SEGER is a portfolio company of The Trendlines Group, located in the Misgav Industrial Park in Israel’s Western Galilee.

Our Team

Shahar Millis

CEO

B.Sc., MBA with more than 20 years’ experience in medical device management and R&D, CEO of Fidmi Medical (GI), experience in cardiovascular and gastrointestinal, leading product development from concept to market.

Prof. Barry Salky

Co-Founder & Medical President

Recognized worldwide pioneer and key opinion leader in the laparoscopic surgery field, developed techniques now considered standard of practice; founder, Laparoscopic Surgery Division, Mount Sinai Hospital, NYC; former VP, SAGES; president, International Federation of Surgical Endoscopic Societies (IFSES)

Leo R. Mindick

Co-Founder & Investor

Founder and CEO, Med-Tech Consultant Partners; years of experience in specialty medical devices, IP, regulatory, reimbursement; founder and former CEO, multimillion-dollar specialty medical distribution company (later acquired)